CY-150112

Primary objective: To evaluate the safety and tolerability of oral administration of CY150112 tablets on an empty stomach in Chinese healthy adult subjects under titration and multiple dosing. Secondary objectives: 1. To evaluate the pharmacokinetic (PK) characteristics of CY150112 tablets and major metabolites (CY150112-9, CY150112-13) in Chinese healthy adult subjects under titration and multiple dosing on an empty stomach; To preliminarily evaluate the effect of oral administration of CY150112 tablets on the QTc interval of subjects.